News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Why Cadence Design Systems Stock Is Back in Focus Cadence Design Systems (CDNS) is …
Sharemaestro market context Trend signal active 52 weeks -14.3%Skye Bioscience announced its definitive agreement to acquire Redx Pharma through a scheme of arrangement under U.K. law for an approximate $125 million deal. The merged entity will be known as Fibrx Therapeutics Inc., trading on Nasdaq, and will be led by Redx's current …
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Cadence Design Systems is back in focus as analysts lift price targets into a US$400 to US$450 range, reflecting a slightly higher Fair …
Sharemaestro market context Trend signal active 52 weeks -14.3%TuHURA Biosciences anticipates preliminary results from its IFX-2.0 study, which combines IFX-2.0 with Keytruda for treating deep-seated Merkel Cell Carcinoma (MCC). These results are expected in the first half of 2027. This study represents a key milestone for TuHURA Biosciences in its development of …
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Cadence Design Systems stock has more than doubled over the past five years, yet the current checks point to a rich valuation that …
Sharemaestro market context Trend signal active 52 weeks -14.3%On August 11, Gilead Sciences, Inc. (NASDAQ:GILD) exercised its option to exclusively license a preclinical bispecific program targeting solid tumors using MacroGenics, Inc. (NASDAQ:MGNX)'s proprietary TRIDENT platform. The decision triggered a $10 million milestone payment to MacroGenics, injecting momentum into the companies' 2022 collaboration. …
Bright Minds Biosciences (NASDAQ:DRUG) reported quarterly earnings per share of ($0.17), significantly surpassing analysts' consensus estimate of ($1.28). Following the announcement, shares fell 2.0% to $76.44. Analysts maintain a generally positive outlook on the stock, with an average "Buy" rating and a consensus price …
Castle Biosciences Inc (CSTL) shares recently dropped 3.0%, leading to a 7.5% decrease over the past week, but GuruFocus' GF Value indicates the stock is slightly undervalued. Despite a strong GF Score of 81/100, driven by high growth potential, the company faces significant challenges …
Legence Corp (NASDAQ: LGN) reported mixed second-quarter results, missing earnings estimates but exceeding sales expectations. Following the announcement, BTIG analyst Gregory Lewis reiterated a Buy rating but lowered the price target from $120 to $100, while BMO Capital analyst Devin Dodge maintained an Outperform …
UBS has reiterated its Buy rating for Kodiak Sciences (KOD.US) and maintained its target price at $80. This indicates a continued positive outlook from the financial institution regarding the company's stock performance.
Perceptive Advisors LLC and related entities, including Joseph Edelman, have reported a beneficial ownership of 12,046,579 shares in Solid Biosciences Inc. (NASDAQ: SLDB), representing an 11.2% stake. This includes common stock and pre-funded warrants, with the latter subject to a 9.99% beneficial ownership limitation …
A holder of CSTL common stock has filed a notice of intent to sell up to 24,908 shares on NASDAQ through Morgan Stanley Smith Barney LLC Executive Financial Services. The indicated aggregate market value of these shares is $741,493.72, and they originated from restricted …
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Tencent Holdings (SEHK:700) is ramping up its global AI efforts with a significant investment in Swedish AI coding startup Lovable. The company is …
Assembly Biosciences (ASMB) stock jumped 10% after reporting significantly reduced losses and increased revenue. The company's net loss from continuing operations narrowed from US$40.177 million to US$6.383 million, and total revenue rose to US$71.097 million. Despite these improvements and an expanded Phase I pipeline, …
This article examines the breakeven prospects for Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company. It focuses on the company's expected path to profitability, specifically the average annual loss of US$34m and the necessity for significant revenue growth to cover these costs. The …
Twist Bioscience Corp (TWST) shares dropped by 5.4% to $118.57, yet the stock is considered 126.4% overvalued compared to its GF Value™ of $52.38. Despite a strong growth rank of 10/10, the company's profitability and valuation ranks are low, coupled with significant insider selling …
An investor group comprising Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. has reported a beneficial ownership of 9.99% in Alto Neuroscience (ANRO). This ownership, totaling 4,176,711 shares, includes common stock and pre-funded warrants, with the exercise of warrants capped …
Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. have reported a beneficial ownership of 1,489,443 shares of Inhibrx Biosciences, Inc. (INBX) common stock, representing 9.99% of the class. This stake includes common shares and pre-funded warrants, with the exercise of …
ADAR1 Capital Management, LLC and Daniel Schneeberger have disclosed a 2.5% beneficial ownership stake in Spruce Biosciences, Inc. (SPRB) through a SCHEDULE 13G/A filing. This stake, totaling 67,717 shares, is held across various managed accounts, with both parties exercising shared voting and dispositive power. …
Edwards Lifesciences Corp. (EW) stock fell 1.04% on Friday, closing at $91.60. This underperformance occurred on a generally negative trading day for the stock market, with both the S&P 500 Index and the Dow Jones Industrial Average also declining. The stock experienced its third …
Bjoern Wylezich Diana Shipping (DSX [https://seekingalpha.com/symbol/DSX]) announced on Friday that it has withdrawn its offer to acquire the remaining shares of Genco Shipping & Trading (GNK [https://seekingalpha.com/symbol/GNK]) after the companies failed to agree on deal terms. The company's withdrawn offer [https://seekingalpha.com/pr/20620174-diana-shipping-inc-withdraws-offer-to-acquire-genco-shipping-and-trading-following-genco] included $24.80 in …
New Providence Acquisition III (NPAC) has detailed its merger plan with Abra Financial Holdings and disclosed going-concern risks in its latest quarterly report. The SPAC reported a Q2 2026 net income of $2.24 million, primarily from trust investments, but faces substantial doubt about its …
Paradigm BioCapital, along with its related entities and Senai Asefaw, M.D., has reported a collective beneficial ownership of 7.8% in Assembly Biosciences (ASMB), totaling 1,553,748 shares. This stake is based on an amended Schedule 13G filing, with Paradigm BioCapital International Fund Ltd. directly holding …
Twist Bioscience director Katryn Blake sold 2,240 shares of common stock on August 12, 2026, at $122.88 per share. This transaction was not a discretionary trade but was executed to cover tax liabilities arising from the vesting of Restricted Stock Units. Following the sale, …
Whitebox Advisors LLC and Whitebox General Partner LLC have reported an updated ownership stake in Wheels Up Experience Inc. As of June 30, 2026, Whitebox beneficially owns 1,021,597 shares of Class A Common Stock, representing approximately 2.8% of the outstanding shares. The filing also …
A Schedule 13G/A filing indicates that Frazier Life Sciences-affiliated funds and individuals have updated their ownership report for Aura Biosciences (AURA). Frazier Life Sciences Public Fund, L.P. directly holds 5.6% of Aura Biosciences' common stock, and other Frazier funds also hold significant shares. The …
Vestal Point Capital, along with its Chief Investment Officer Ryan Wilder, has reported a beneficial ownership of 4.8% in Solid Biosciences Inc. (SLDB). This stake includes 4,833,796 common shares, of which 2,673,796 are issuable upon the exercise of pre-funded common stock purchase warrants. The …
Search by ticker symbol or company name and select a result to open its chart.